ArticleClinical ophthalmology (Auckland, N.Z.)2019

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion.

Kazuyuki Kumagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.